Total Payments
$505.35
2024 Payments
$113.01
Companies
6
Transactions
29
Medicare Patients
1,230
Medicare Billing
$119,609
Payment Breakdown by Category
Food & Beverage$505.35 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $505.35 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $372.37 | 22 | $0 (2024) |
| Allergan, Inc. | $53.91 | 3 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $28.45 | 1 | $0 (2021) |
| Amgen Inc. | $18.41 | 1 | $0 (2022) |
| Celgene Corporation | $18.30 | 1 | $0 (2022) |
| Lilly USA, LLC | $13.91 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.01 | 5 | ABBVIE INC. ($113.01) |
| 2023 | $69.30 | 3 | AbbVie Inc. ($69.30) |
| 2022 | $208.77 | 15 | ABBVIE INC. ($154.49) |
| 2021 | $114.27 | 6 | Allergan, Inc. ($36.34) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Neuroscience | ||||||
| 04/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Neuroscience | ||||||
| 02/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 388 | 503 | $95,323 | $36,099 |
| 2022 | 9 | 394 | 468 | $103,336 | $37,280 |
| 2021 | 11 | 401 | 467 | $100,648 | $41,905 |
| 2020 | 3 | 47 | 47 | $11,989 | $4,325 |
Total Patients
1,230
Total Services
1,485
Medicare Billing
$119,609
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 205 | $32,176 | $11,620 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 109 | $21,146 | $8,882 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $8,613 | $3,456 | 40.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 20 | 20 | $7,080 | $2,544 | 35.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 33 | 52 | $4,056 | $2,165 | 53.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $4,103 | $2,052 | 50.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 18 | 18 | $5,382 | $1,827 | 34.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 16 | 24 | $4,416 | $1,540 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,873 | $1,072 | 37.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 21 | 22 | $5,478 | $941.38 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 158 | $25,709 | $9,650 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 84 | $18,833 | $7,457 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $20,493 | $7,434 | 36.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $9,672 | $3,823 | 39.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 31 | 42 | $7,728 | $3,275 | 42.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 23 | 23 | $6,877 | $2,259 | 32.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 33 | 36 | $8,964 | $1,353 | 15.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,380 | $1,323 | 39.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 11 | 14 | $1,680 | $705.63 | 42.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 87 | $16,878 | $7,878 | 46.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 110 | $16,280 | $7,551 | 46.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 56 | 87 | $16,008 | $6,891 | 43.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $16,335 | $6,609 | 40.5% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 16 | 16 | $5,968 | $3,283 | 55.0% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 22 | 22 | $6,578 | $2,358 | 35.9% |
About Dr. Jessica Ahlum, MD
Dr. Jessica Ahlum, MD is a Clinical Neurophysiology healthcare provider based in Lewisburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2015. The National Provider Identifier (NPI) number assigned to this provider is 1518354091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Ahlum, MD has received a total of $505.35 in payments from pharmaceutical and medical device companies, with $113.01 received in 2024. These payments were reported across 29 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($505.35).
As a Medicare-enrolled provider, Ahlum has provided services to 1,230 Medicare beneficiaries, totaling 1,485 services with total Medicare billing of $119,609. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Lewisburg, PA
- Active Since 04/22/2015
- Last Updated 05/17/2023
- Taxonomy Code 2084N0600X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518354091
Products in Payments
- QULIPTA (Drug) $202.02
- UBRELVY (Drug) $170.35
- BOTOX (Biological) $53.91
- NURTEC ODT (Drug) $28.45
- Aimovig (Biological) $18.41
- ZEPOSIA (Drug) $18.30
- EMGALITY (Drug) $13.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.